Forces of nature – strategy+business Today

The concept of a business ecosystem was firstarticulated by the strategist James F. Moore in his seminal1993 Harvard Business Review article, Predators and Prey: A New Ecology of Competition, and the idea has since gained substantial currency. A business ecosystem is a community of enterprises and related organizations that coevolve over time and align themselves with directions set by one or more central companies. Examples of business ecosystems include a computer company and its users, investors, and third-party app developers; or an energy company with its network of suppliers, customers, traders, and resellers; or an auto manufacturer and the suppliers, retailers, and marketers that surround it.

The ecological analogy is apt because it emphasizes the fact that ecosystem members may both cooperate and compete with one another in complex ways that lead the entire community of enterprises to thrive. But theres a key difference between biological and commercial ecosystems. In nature, ecosystems can survive and thrive for long periods of time, almost in perpetuity. By contrast, business ecosystems tend to fall apart in a matter of decades, and the clock speed seems to be increasing. Furniture manufacturers near High Point, N.C., flourished for more than a century after reaching critical mass in the 1890s, whereas the minicomputer ecosystem, located along Massachusettss Route 128, lasted for less than 30 years after its 1960s heyday.

How can business ecosystems emulate the vitality and longevity of their biological equivalents? An answer may be found in what Canadian ecologist C.S. Holling(pdf) called the adaptive cycle. This cycle is a natural process, often represented as an infinity loop, that perpetuates a natural ecosystem through repeated destruction and rebirth. Organisms are born, and they grow and mature and reproduce. And then they decline, so that the overall structure of species continually improves. But it doesnt happen in steady, linear fashion. Instead, the dynamic ecological balance has long processes of growth, which Holling framed as exploration and conservation, offset by periods of rapid meltdown and renewal, which Holling called release and reorganization (see The adaptive cycle).

In a natural ecosystem such as a forest, the earliest growth phase (exploration) begins in an open patch, where all organisms have equal access to sun and rain, and everything grows in an unconstrained fashion. In business, this is analogous to the first part of an S curve, in which growth processes accelerate. First movers and fast movers flourish, like so many weeds.

But this loosely connected startup system does not last for long. Exploration gradually gives way to exploitation and, eventually, conservation. Early fast-growing organisms bump into others, and competition for resources breaks out. In a forest, the resources are sun, rain, and soil nutrients. In a startup industry, the resources are capital, skilled talent, and access to customers. The survivors are those who capture resources first and, even more important, exploit them efficiently, typically through economies of scale.

As exploration and exploitation proceed, the forest matures, going through a well-recognized succession: from weeds to shrubs to small trees and, eventually, large trees. The trees are the equivalent of efficient, substantial, tightly connected hierarchies; they hog the sun and the rain. Other plants struggle to grow in their shade. In this phase, little new development (for example, the development of other new species) is possible. Similarly, in business, mature and stable enterprises come to dominate the value chain, the limits of the market are recognized, and the growth of the sector levels off.

Ecologists used to think that this mature conservation phase was a stable or even permanent condition, but it is not. Retail shopping malls are a case in point, as traffic through them dwindles under the onslaught of online competition. Evolution is still taking place in nature as well as technology and room must be made for the new. Startup conditions must be recreated. In nature, destructive natural processes such as wind, fire, flood, and pestilence open up the forest canopy and create spaces for new growth. They sweep away the tall hierarchies, which were rendered vulnerable by their inflexibility and inability to resist attack, and release their components as resources for the next generation. Reorganization follows rapidly. Those elements that were released into the soil are recombined to become nutrition for the next generation of organisms. In business, this process is called creative destruction or disruption: Old enterprises break apart and their human and capital resources migrate to the new, and the adaptive cycle begins again.

Of course, theres a big difference between forests and corporations. The latter are populated by sentient humans who try to influence outcomes. Now imagine being inside an organization during this adaptive cycle. As human beings, business decision makers are more active than trees. They cant change the cycle itself, but they can react to it, with one of three emphases:

Passion: innovators creating startups and bringing them to life

Reason: managers and leaders making deals and organizing more effective operations

Power: administrators using their position and resources to force others to comply with their policies, strategies, and procedures

The resulting infinity loop is analogous to natures adaptive cycle. But its not exactly the same. And it goes through its own phases (see Adaptive cycles in business). The solid line is the slow front loop of the cycle; the dotted line is the fast back loop:

In the Passion stage of the cycle, enterprises are conceived as communities of trust. The innovators who founded them are free to act but often dont know what to do. They are guided by their passions and those of the communities in which they find themselves. They may take the advice of Apple cofounder Steve Wozniak to try to make valuable what they are good at, or they may try to solve an irritating problem. In 1995, for example, Sabeer Bhatia and Jack Smith, who worked together at Apple, were annoyed when the corporate firewall prevented them from accessing their personal AOL email accounts. So they invented Web-based email. Hotmail, the company they founded, sold in 1997 to Microsoft for shares valued at US$400 million.

Most nascent enterprises die in the early stage, because passion is not sufficient to guarantee commercial success. Those startups that survive develop a logic for their value creation process and assemble their value chain, moving into a stage of Reason. Former innovators evolve into managers. They are still free to act, but now they know what to do and their task is clear: to scale the enterprise as rapidly as possible. As companies move into the Reason part of the cycle, their priorities become raising financial resources, managing growth, recruiting people, and preserving the startup culture.

But these priorities become increasingly challenging as scale and geographic dispersion grow. According to anthropologist Robin Dunbar, head of the Social and Evolutionary Neuroscience Research Group at Oxford University, the maximum number of personal relationships that human beings can comfortably maintain is about 150. So once an organization grows beyond that size, more formality is required. Managers must turn to the panoply of mainstream management methods.

They do so for the very best of reasons: to embed and preserve the enterprises recipe for success. If the firm has gone public to raise capital and monetize the founders stakes, this is especially important. The corporation will have to deal with a slew of new stakeholders who require formal communication in prescribed formats and who look for high performance. Demand increases for professionals with technical skills, even if they dont fit with the original startup culture. Tension grows as jobs become specialized, activities are specified, processes are formalized, and a hierarchy emerges.

As more and more constraints are introduced, the corporation moves into the Power stage. The organizations members find that though they know what ought to be done, they are not always free to act. In the early entrepreneurial days, if they needed a resource, they had to find or create a customer. Their focus was external, and they were free to go anywhere. Now if they want resources, they have to navigate a bureaucratic maze, negotiate budgets, and fight turf wars. Their focus is internal. They are hamstrung by policies and processes and constrained by narrow job definitions. At the top of the organization, senior managers live in a world of simplifying abstractions reports and metrics that allow them broad scope in what they can manage, but lack depth. Leaders must make extraordinary efforts to find out what is really happening on the ground. The top of the corporation may now become a self-regarding autocracy. Like a mature forest, incapable of responding to change, the corporation is set up for crisis and destruction, unless it can find its way to renewal.

Unfortunately, most corporations are not well equipped for the crisis and confusion that typically follow. To respond effectively, business leaders must shatter the tightly connected structures that constrain peoples activities and limit the ways in which resources can flow through the system. They must recreate startup conditions in which small-scale experimentation is possible. Leadership (as opposed to management) now becomes critical as the original purposes of the organization are rediscovered and renewed. To get the organization back to its roots, the leaders must stop focusing on their own internal hierarchy and get back to the field, where value is created and destroyed.

Vanishingly few large organizations commercial or otherwise have managed to pull off this pivot. One prominent example of such activity on a world stage is one of the oldest continually functioning organizations in the world: the Roman Catholic Church. When Pope Benedict XVI resigned in 2013, the College of Cardinals replaced him with Cardinal Bergoglio (Pope Francis), the first Jesuit ever to become pope. The Jesuits, along with some of the other religious orders, have traditionally been the change agents of the Catholic Church. For instance, the Jesuits led the Counter-Reformation movement, the process of renewal that saw the corrupt Renaissance Church reformed and returned to a focus on its customers: the communities and parishes. Clamped to the side of the church, of it but not in it, the Jesuits live ascetic lives that would be disruptive of the broader community if allowed free rein. Here they wait for the day when they will be needed to take the church back to its roots. Since his installation in 2013, Pope Francis has led by example. He refuses to live in the Vatican Palace, to wear the mitered crown, or to ride in luxury limousines. All of these trappings of power, he believes, get in the way of people telling him what is really happening. He has described the Vatican-centric church bureaucracy, the Roman Curia, as narcissistic, self-referential, and the leprosy of the Papacy. With his newly created Council of Cardinal Advisors to counsel him on how to structure the Curia, he thinks of his search as one for a new balance and for an organization that is horizontal, not just vertical.

On the back loop of the cycle, the role of leadership is to gather up the fragments of the old structures into new configurations, and to create a social, even spiritual movement around a new narrative that outlines the organizations mission, its reason for being. With the articulation of that mission, people are brought back into a new community of shared values and trust. The organization now finds itself once again in the top left portion of the cycle, where people are free to act, guided by their passions and experiences and those of the communities to which they belong.

A successful company can make its way around this cycle several times in a century. But most dont, because their leaders fall into one of two major traps, as shown in Adaptive cycles contain two major traps.

On the left of that diagram is the failure trap (or poverty trap), in which the community develops numerous options but none get beyond the first stage. Business intelligence firm CB Insights has documented the top 20 reasons startups fail: The top three are a lack of market need, a lack of cash, and a failure toassemble the right team. On the right is the rigidity trap (or competence trap), in which the organization simply cannot let go of the processes and procedures that have made it successful and thus cannot renew itself. Kodak spun in the rigidity trap for decades before it declared bankruptcy in 2012. It had pioneered digital photography in 1975 but then tried to use it to prop up its film, paper, and chemical businesses. These efforts did not succeed.

The failure trap has been around forever, and the rigidity trap has been a feature of large-scale organizations ever since they emerged in substantial numbers after the Industrial Revolution. Walter Bagehot, founder of the Economist, wrote in the middle of the 19th century about the difficulty that institutions experienced getting out of a fixed law; not of cementinga cake of custom, but of breaking the cake of custom; not of making the first preservative habit, but of breaking through it, and reaching something better. History is littered with examples: the stuffiness and conservatism of family firms in Great Britain at the turn of the 19th century, the inability of U.S. railroads to adapt to the rise of trucking in the 1950s, the collapse of the U.S. television manufacturers in the 1970s, the helplessness of the Detroit automakers in the face of Japanese competition in the 1980s, and the shocking falls of many well-known companies that made computers and handheld communications devices more recently.

The problem is so pervasive that its root causes must have a strong systemic component. Firms dont fall into the rigidity trap simply because of personal failings, management myopia, or executive complacency. These may be symptoms, but they are not root causes. The root causes lie in the context of large complex ecosystems.

If organizations are like ecosystems, shouldnt they be able to live in perpetuity, continually renewing themselves? They could, but only if they are capable of structuring themselves as genuine ecosystems and finding a way to dwell in the sweet zone of continuity and change that lies between the twin traps of rigidity and failure. It is difficult to name many Anglo-American corporations that have been able to do this for any length of time. Intel went through one renewal when, in the mid-1980s, it switched from making random access memory (RAM) chips to microprocessors, but it seems to be struggling with the shift to mobile. IBM under Louis Gerstner in the 1990s made the jump from hardware to software, but now seems stuck again. Netflix managed to switch from sending DVDs through the mail to a streaming service, but perhaps that was not too much of a challenge, as it preserved its basic subscription model. At one time, when it was a medical and scientific instrument company, Hewlett-Packard seemed capable of indefinite renewal. But it apparently lost this ability when it entered the large-scale systems business. HP spun off the instrument business as Agilent in 1999, so maybe one can think of the old HP as alive and well and living under an assumed name.

Given the burdens of being a publicly held company, it seems likely that the purest examples of organizations-as-ecosystems may be privately owned companies. Firms like Cargill, Hallmark Cards, S.C. Johnson, and Tata Group come to mind. Private ownership insulates organizations from the short-term demands of quarterly reporting, reduces the allure of debt and careerism, encourages frugality, and allows companies to focus on resilience, sustainability, and the long term. Family firms have their own pathologies, but well-run examples may fill the bill.

W.L. Gore & Associates, best known for its invention and production of Gore-Tex fabric, is frequently cited as an example of such a company, with its flat, lattice organization structure that delivers hierarchy on demand and physical clusters of businesses, none of which exceeds more than a few hundred people in size. Company leaders seem to act more as gardeners than as engineers, continually cultivating the soil in which people and new ventures can take root and grow. Of course, its basic technology plays an enabling role here. Gores versatile PTFE (polytetrafluoroethylene) technology allows the small-scale manufacture of myriad high-margin spin-off products in the medical and high-tech fields. It is almost impossible to imagine how an integrated steel mill could organize itself inthe same way.

Statistical evidence also suggests that, in practice, corporations cannot live in perpetuity. Geoffrey West of the Santa Fe Institute has done extensive work in contrasting corporations with cities and examining how they scale. Both show economies of scale as they grow a city doubling in size doesnt need twice as many gas stations; it needs about 1.85 times as many. But as cities grow, their outputs grow faster than they do. According to West, in contrast with cities, all corporations eventually die.

I believe that West based this conclusion in part on a misreading of corporate vitality. He observed that corporations die when they stop reporting financial results. So he records YouTube as having died when it was acquired by Google in 2006 yet it is a stronger and healthier organization than before. Setting aside these data flaws, however, Wests belief that cities tolerate fringe activities much more readily than corporations do seems sound. As a result, the corporate bureaucratic side and the imperatives of economies of scale steadily overwhelm the innovation dynamics present at the businesss founding. This assumption certainly seems to square with the ecological narrative, and it is a powerful reminder that in nature what survives is the ecosystem, whether or not each individual organism that makes up that ecosystem survives.

In ecosystems, stability and change are entangled with each other: Stability is achieved only through change and vice versa. Nothing lasts unless it is incessantly renewed. Natural ecosystems have evolved to renew themselves automatically. To some extent, so have human ecosystems, albeit less perfectly. Both democracy and capitalism have ecological features, but they and their component institutions and organizations are prone to getting stuck in rigidity traps. Humans seem to have an attraction to hierarchical power and the status quo that trees do not share. But change cannot be postponed indefinitely. As conservative politician and philosopher Edmund Burke wrote, A state without means of some change is without the means of its conservation. In his book Management: Tasks, Responsibilities, Practices (1973), Peter Drucker, legendary management writer and self-described social ecologist, contended that every organization had to be sloughing off yesterday and that managers had to learn to run, at the same time, their existing managerial organization as well as a new innovative one.

In ecosystems, stability and change are entangled with each other: Stability is achieved only through change and vice versa.

The only way to do this is to run them as true ecosystems. This takes enormous focus and dedication on the part of an organizations managers. It demands spaces for constant conversation and experimentation. As an organization scales, system dynamics propel it inexorably toward the top right conservation phase where power rules. Purpose is lost as what were once means become ends in themselves. Short-term reward systems and cultures bent on financial maximization can plunge a firm into a rigidity trap, where fierce competition within the corporation erodes trust. Ed Catmull, a pioneer in digital animation and former president of Pixar and Walt Disney Animation Studios, describes the challenge of keeping power and structure out of the creative process as a Sisyphean task.

Capitalism is a process of creative destruction. But taking an ecological perspective reminds us that creation and destruction operate on different timetables and in different contexts. The dynamic balance between the two is a central problem of management, and a true decision area at all levels of the ecosystems in which we live and work and on which we depend.

View original post here:
Forces of nature - strategy+business Today

Once and for all: No, we didnt get the coronavirus from bats – Haaretz

Lets start from the punch line: Bats did not give us the latest coronavirus. Nor were its notorious cousins SARS-1 or MERS, or even the ebola virus, transmitted from bats to humans. So what did happen?

A distant relative of the current coronavirus, SARS-CoV-2, was isolated in a bat in China. Genetic analyses that looked for similarity between the virus in the bat and SARS-CoV-2, and factored in the theoretical pace at which the virus mutates, estimated that the two viruses parted ways between five and 50 years ago. In other words, one possibility is that about five years ago, the bat coronavirus managed to infect some other different animal we dont know which one at this time. In that next animal, the coronavirus lived and mutated over those five years, and one day infected a human for the first time. There are other hypotheses as well.

Israels single-use coalition will serve Trump and protect BibiHaaretz

Coronavirus tracker: Live statistics of cases and deaths in Israel and around the world>>Latest coronavirus stories

Science doesnt yet know where the coronavirus lurked in wait for the past few years, or when it became dangerous to people, or when the first person was infected, nor do we know which animal infected that first human. The only thing science knows for sure is that the coronavirus isolated from the Chinese bat cannot have infected humans and isnt dangerous to them.

Read more:Should men be worried about coronavirus because of their testicles?|Israeli researchers developing treatment to save COVID-19 patients' lungs

This fact was published two months ago, based on the genetic sequences of the bat and human viruses. This is also true in the cases of SARS, MERS and ebola despite repeated efforts to locate these viruses in bats, all that researchers found were similar viruses, or evidence of previous exposure that doesnt mean they carried the virus routinely and certainly not that they passed it to humans, despite reports that have appeared in the general press (including in Haaretz Hebrew edition, on April 19).

Bat Out of Hell

We've got more newsletters we think you'll find interesting.

Please try again later.

The email address you have provided is already registered.

Why do bats get such bad press in connection with viruses? In recent years there have been increasingly strident claims that bats carry zoonotic viruses, which can infect humans. But there are serious scientists who disagree with this and argue that bats are no different than other mammals in the number of zoonotic viruses that they carry, certainly if you consider the large number of species in the bat family. Around a fifth of all the worlds mammals are bats.

There are several batty characteristics that render them suspect when it comes to viruses. Their ability to fly, their presence in all parts of the world, their large colonies and the crowding in which they live; their long lives; and their proximity to humans all make them ostensibly suited to transmitting diseases.

The fact that they are mammals increases the chance of their being transmitters. This is why searching for new viruses in bats has become almost a fad among researchers; and the more in-depth the search, the more likely something will be found.

Moreover, accumulated findings show that the bat immune system is unique among mammals, and skilled in dealing with viruses. This immune system enables bats to fend off viruses, including deadly ones, by means of a moderate inflammation response that leads to immunity. As a result, many studies find antibodies in bats proof that theyve been exposed to viruses without finding the virus itself.

Without the live virus itself, the bat cannot be a carrier and certainly cant be a transmitter. This means that the important link in the chain of zoonotic transmission to humans is still missing.

Eating a bat when it is sick could cause infection, just like eating any other sick animal could, and is not recommended. As a general rule, to reduce the chance of zoonotic transmission of viruses from bats or any other animals, its best to eat them infrequently and in general to minimize encounters with them; to let them live in their natural environments and stop invading their habitats.

Its interesting to note that the amazing bat immune system apparently developed to support its unusual way of life. Bats live longer than almost any other mammals. In 2006 a Brandts bat (Myotis brandtii), weighing a mere 7 grams and about the size of your finger, was recaptured after it had been tagged by scientists in Siberia 41 years before! A mouse of similar size wouldnt live for more than two years. Such extreme longevity requires an optimal immune system.

Bats flying ability, unique among mammals, seems to have also contributed to the development of its immune system. In our studies weve found that small bats weighing no more than 30 grams can fly a distance of more than 250 kilometers in a night. The energy needs and accelerated metabolism during flight are accompanied by oxidative damage, which requires an appropriate immune system. Some believe this immune system is why bats very rarely develop cancer.

In addition, a bat who leaves its cave in the evening raises its body temperature by a few degrees within a minute. This elevated body temperature, which reaches 40 degrees Celsius or more, apparently helps kill undesirable viruses and bacteria.

Its important to stress that our love for bats hasnt blinded us (bats arent blind either, by the way). There are zoonotic viruses that are transmitted by bats such as Marburg, Hendra, Nipah and bat rabies, none of which are found in Israel. Bat viruses should be accorded the respect they deserve, but theres no reason to credit bats with viruses that arent theirs.

Prof. Yovel and Dr. Weinberg teach in the zoology department of Tel Aviv Universitys life sciences faculty.

More:
Once and for all: No, we didnt get the coronavirus from bats - Haaretz

7 Ways This Vegan Teenager Wants You to Use Self-Quarantine to Change the World – VegNews

Erin Ersoy first caught our attention after pledging to spend 12 hours in a bathtub to protest SeaWorlds confinement of sealife. However, this 14-year-old cancer survivor has lent her time and efforts to a number of causesfrom establishing herself as a leader for youth activists to utilizing her compelling Instagram page to create awareness around animal cruelty. Her fresh, Gen Z perspective opened our minds to the possibilities of activism at home.

How Im Changing the World During QuarantineAnd How You Can, TooBy: Erin Ersoy

When your ability to keep calm and carry on is stifled by the Stay-at-Home mandate, some may be at a loss for what to do. For those of us who find purpose and fulfillment in activism, were experiencing major withdrawal. It may make seem difficult or even impossible to take action while practicing self-isolation, but speaking up for the voiceless is still entirely possible; we just need to take a creative pivot. Here are seven ways you can take action today.

1. Hold an online documentary screeningPeople are holding online movie screenings using the Google Chrome extension Netflix Party, which allows friends to gather virtually, watch the same movie on Netflix, and chat at the same time in a text box. People have also started screen-sharing movies on Zoom. You can hold a screening of conversation-sparking documentaries such as The Game Changers on Netflix and Dominion on YouTube, amongst others. Its an awesome way to educate your friends and family members on the benefits of a vegan lifestyle.

2. Sign online petitionsMany organizations already offer online petitions, but now that people are home and looking for online action options, even more organizations are bringing their causes online. Taking action and making an impact is as simple as filling in your contact information and clicking submit. To start, consider asking the US Dietary Guidelines Advisory Committee to remove dairy as a food group from the upcoming 2020-2025 recommendations. This form included a pre-filled comment, just add your name and contact information.

3. Give your friends and family a callA lot of us now rely on making phone or video calls to connect with our family and friends. During your next check-in, spark a casual conversation about veganism. Ask what theyve been cooking at home, and if they complain of meat or egg shortages at the store, gracefully land a comment about the abundance of produce or frozen vegan meat options. Having a nice, calm, and polite discussion about the benefits of a plant-based diet is a great way to get people to consider going vegan. Its not like they have social obligations or any of the other typical excusesnow is the time to give vegan a try!

4. DonateRight now, many vegan organizations and animal sanctuaries are having difficulty generating the funds they need to continue operations. Its certainly tough when competing with the charitable efforts related to the current pandemic (which are also worthy causes). If you have the means, a simple donation can help necessary nonprofits continue their work to promote the vegan message. Similarly, many vegan restaurants are offering donation options for their pickup and delivery customers. These extra dollars are put toward providing free meals for first responders or the hungry, or ensuring that staff can continue to receive a living wage.

5. Get socialStuck at home, bored, and perhaps alone, social media might be the only thing keeping you connected to the outside world (thats okay; were all going through it). However, social media can be used for so much more than drooling over vegan food photos and watching animal videos; its also a terrific tool for activism. Instagram has been a hot spot for new virtual activism challenges such as Greta Thunbergs #ClimateStrikeOnline, the Save Movements #CoronavirusConfinementChallenge, and PETAs #SeaWorldBathtubChallenge. Let the tagging and hashtagging begin!

6. Make a piece of artHave you ever heard of artivism? Its a trending form of activism that involves using a creative approach to serious issues. Make a poster with a fact about veganism and tape it to the window for people outside to see, create a symbolic painting and post it on social media, or embrace your inner six-year-old and make meaningful chalk drawings. Let your creativity feed your activism.

7. Educate yourselfDo you know how much water it takes to produce a gallon of cows milk? What about the meaning of CAFO and how these operations are creating a hazardous living environment for low-income communities in North Carolina? Now is the time to equip yourself with this information in order to be a more effective vegan advocate. Listen to an audiobook of The China Study while enjoying your ritual afternoon walk, watch vegan-themed TedTalks (try Pat Brown and Melanie Joy), or read up on vegan nutrition (Brendan Braziers Thrive offers a solid foundation). The more you know, the better you can represent the vegan movement.

Erin Ersoy is a 14-year-old vegan activist from New York who leads the Raven Corps Long Island and the Youth Climate Save New York.

Please support independent vegan media and get the very best in news, recipes, travel, beauty, products, and more.Subscribe now to the worlds #1 plant-based magazine!

See more here:
7 Ways This Vegan Teenager Wants You to Use Self-Quarantine to Change the World - VegNews

The Truth About Vegan Cheese: And Tips To Find The Best – Plant Based News

Which vegan cheese should you opt for?

Morrisons has just launched a range of vegan cheeses, including smoked, mature and jalapeno. These cheeses are fantastic, but can cause so many issues with new vegans and I just wanted to explain why and offer some advice.

Firstly, if you are reading this and you are new to veganism, or just curious, then its important not to get your hopes up to find a vegan cheese that will imitate a dairy cheese.

The new cheeses at Morrisons and other major supermarkets are based on coconut oil, which helps the cheese melt, but doesnt mimic the taste of dairy.

Brands like Violife offer a range of vegan cheese options (Photo: InstagramAlternative Stores)

Even as a lover of vegan cheese, in my opinion there is still no block that matches dairy. Dairy cheese contains casein, which is actually addictive and our brains know the difference.

Vegan cheese can match the saltiness, the fattiness and even now the meltiness, but so far we dont have anything that replaces the casein.

My thoughts are that the wizards behind the Beyond Meat burgers and Just Egg will come up with something in a lab that replicates it almost perfectly, but so far in the UK there isnt anything.

Theyve nailed plant-based meats, they are amazing and almost exactly like the real thing, but we are still searching for the holy grail when it comes to vegan cheese.

Lots of brands are making vegan cheese - but have yet to perfectly replicate dairy-based alternatives (Photo: Vitalite)

Everyday I see members of the Vegan Food UK community ask this exact question: "Is there ANY vegan cheese that doesnt taste vile?

The answer to this is yes, but in comparison to dairy, you will be quite disappointed.

My advice and model for success is to go vegan and give up all cheese for a few weeks or even months. Let the body adjust to not consuming casein and then start your dairy-free cheese journey.

First thing to do after your cold turkey (horrible expression) has been well and truly served, is to move onto a mild vegan cheese that melts.

Applewood vegan is a popular option for many plant-based eaters(Photo: Supplied to Plant Based News)

By now you will probably miss having melted cheese on food? The good news is that there are a few to choose from, but the key is to go for something neutral like Violife Original. It melts well and wont offend your taste buds too much.

Once you get used to melted Violife, you can up the ante and move onto something with a bit more flavor and depth, like the Vegan Applewood Smoky Block, which melts even better than Violife.

What about pizza? In my opinion pizza cheese needs to be light without too much flavour. A perfect cheese for this is MozzaRisella: a brown rice milk based mozzarella cheese that melts perfectly on pizza. Its so good that Zizzis, Pizza Express and even Co-op have used it for their pizzas.

Zizzi uses MozzaRisella on its vegan pizzas (Photo:Supplied to Plant Based News)

Something also worth considering from the get-go are nut-based cheeses, which I regard as some of the best cheeses in the world. Use social media to seek them out, but also your local health store should stock a few. These are cheeses to be proud of and are usually made with cashews.

If you have followed my advice and arent satisfied with any cheese that you have tasted so far, then have a go at making your own. You will be amazed with what a bag of cashews and some nutritional yeast can do.

Here is the original post:
The Truth About Vegan Cheese: And Tips To Find The Best - Plant Based News

Global Vitamin D Supplements Market Insights, 2020-2025 – Rising Trend of Veganism Positively Influencing Market Growth – ResearchAndMarkets.com -…

The "Vitamin D Supplements Market - Growth, Trends and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering.

Global vitamin D supplements market is projected to grow at a CAGR of 7.2% during the forecast period of (2019-2024).

Vitamin D supplements are increasingly recommended to children, especially due to its deficiency majorly found in children, and also because it performs a host of physiological functions.

Both forms of Vitamin (D3 and D2) are commonly found in daily diets. While both the types help in meeting vitamin-D requirements, they differ in a few important ways. Some researches suggest that vitamin D2 is less effective than vitamin D3 at raising vitamin D levels in blood, which has made it popular among consumers in the United States.

Dietary supplements are continuously evolving, in order to cater to the niche population segments (pregnant and breastfeeding women, geriatric, and pediatric nutrition) and due to intensive fortification initiatives undertaken by governments, the world over. The increasing awareness related to vitamin supplements has led to favorable sentiments toward the vitamin supplements market.

Key Market Trends

Growing Acceptance of Dietary Supplements in Healthy Diets

Dietary supplements, such as vitamins, minerals, botanicals, enzymes, fatty acids, and proteins, help promote general health and well-being, by preventing nutritional deficiency diseases. The preferences for dietary supplements is growing tremendously due to the global demographic trend with rising aging population, increasing lifestyle-related diseases, and increasing costs of healthcare.

Increasing sales of sports nutrition on account of growing fitness trends and sports activity, with new product launches is likely to have a significant impact on the industry. Regulatory agencies are paying more attention to the dietary supplement health claims and hence, the industry is becoming more regulated.

North America Holds the Largest Share of the Global Vitamin D Market

Publicized studies in North America have a suggested a link between vitamin-D supplementation in palliation of autoimmune symptoms, a reduced risk of bone fractures and the prevention of certain types of cancers in specific subsets of the American population, scientific evidence supporting a contrarian view is emerging, which has been looked upon, as one of the most lucrative opportunities of the vitamin-D supplements market.

With the rising trend of veganism across every region of the world, the consumers in North America are also seen preferring supplements, tailored with vitamin D2 and not vitamin D3, since, the former does not come from an animal source. For example, In the United States, vitamin D2 is more commonly used in the country, in order to fortify milk. The population of North America is highly affected by the deficiency of vitamin D, causing them rickets. thus, leading to the demand for vitamin D supplements.

Competitive Landscape

The leading participants, including Pfizer, The Nature's Bounty Co, Amway, Pfizer Inc., and GlaxoSmithKline plc., holds the largest share of the market. The established players in the market are focusing on rapid expansion and new product launches, in order to gain a better market share, efficient results, and competitive edge over newer competitors.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Drivers

4.2 Market Restraints

4.3 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Product Type

5.1.1 Vitamin D2 Supplements

5.1.2 Vitamin D3 Supplements

5.2 By Distribution Channel

5.2.1 Supermarkets/Hypermarkets

5.2.2 Pharmacies/Health Stores

5.2.3 Online Retailing

5.2.4 Other Distribution Channels

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 South America

5.3.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

6.1 Most Active Companies

6.2 Most Adopted Strategies

6.3 Market Share Analysis

6.4 Company Profiles

6.4.1 Amway

6.4.2 General Nutrition Centers, Inc.

6.4.3 Otsuka Holdings Co. Ltd.

6.4.4 Everidis Health Sciences LLC

6.4.5 Sapien Products LLC

6.4.6 Pfizer Inc.

6.4.7 The Nature's Bounty Co.

6.4.8 THQ Nordic AB

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/6kwzfk

View source version on businesswire.com: https://www.businesswire.com/news/home/20200429005733/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Continued here:
Global Vitamin D Supplements Market Insights, 2020-2025 - Rising Trend of Veganism Positively Influencing Market Growth - ResearchAndMarkets.com -...

One-fifth of UK consumers reduce meat consumption during outbreak, The Vegan Society reveals – FoodIngredientsFirst

30 Apr 2020 --- A fifth of UK consumers have cut down on their meat consumption during the COVID-19 pandemic, according to a survey conducted by The Vegan Society. It also found 15 percent have reduced their dairy/egg intake over the lockdown period. These figures highlight how pressures on supermarkets and consumers are changing buying behavior towards a more ethical, compassionate alternative, says the Vegan Society. Particularly in a time of crisis, peoples purchasing habits can tell you a lot about what the future might hold for the industry, a spokesperson tells FoodIngredientsFirst.

The data shows three main strands behind why people are opting for plant-based alternatives instead of meat or dairy products: these are the fact that their preferred product isn't on the shelves, the desire to improve the rights of animals, the environment or their own health and lastly, the cost of meat and dairy produce, The Vegan Society spokesperson comments.

Its really encouraging to see 20 percent of UK consumers reduce their consumption of meat in favor of plant-based alternatives, they highlight.

Out of those who have reduced their meat or dairy consumption, 41 percent did so due to their preferred product not being available on the supermarket shelves, while 43 percent chose to reduce their meat consumption out of concern for health, environmental or animal rights reasons, data from the study reveals.

The cost of meat products was also noted by respondents, with 15 percent opting for alternatives due to the price of meat in the supermarkets, highlighting how creeping financial pressures are contributing towards a shift to plant-based alternatives.

Click to EnlargePlant milk is also proving to be popular, with 54 percent and 42 percent of those who have tried soya milk and almond milk respectively saying they will make them a regular purchase.Meanwhile, plant milk is also proving to be popular, with 54 percent and 42 percent of those who have tried soya milk and almond milk respectively saying they will make them a regular purchase once the lockdown has been lifted. The most popular being almond milk (42 percent), meat alternatives such as vegan sausages and burgers (38 percent), soya milk (36 percent) and pulses such as lentils and chickpeas (34 percent), says The Vegan Society.

The issue of cost is particularly important, as some corners of the media seem to think that veganism is an unaffordable lifestyle for many. The reality is anything but. Swapping out mince for lentils or chickpeas, for example, or choosing fresh vegetables over meat produce, is actually rather cost-effective and doesn't sacrifice flavor. Consumers are starting to understand this, says the spokesperson.

People have also become more conscious of the damaging impact that animal agriculture has on the planet, as well as how exploitative the practice is towards farmed animals. This is definitely contributing to the shift towards plant-based products, they note.

Interestingly, many of the one in five Brits are fans of the new plant-based alternatives theyve tried and have committed to buying them. Half of those who have also tried vegan meat alternatives such as vegan burgers and sausages have said they will keep on purchasing them.

There is no better time for innovators to explore new plant-based options, continues the spokesperson. The demand for these products is at an all-time high and supermarkets, restaurants and brands are all looking for ways to catch up with the demand and launch new, vegan products. The plant-based boom has only just begun, they remark.

Lots of UK supermarkets are imposing a limit of three per product to limit stockpiling, and this is the case with many products, not just vegan ones. Supermarkets and suppliers are facing an unprecedented situation, we are sure they are doing all they can to keep up with this increased demand for vegan alternatives to meat and dairy, adds the spokesperson.

People are spending more time than they usually would at home, and this has given families more time and space to cook and try out new recipes or being more creative in the kitchen. This might explain why some people have decided to take a leap of faith and try a vegan alternative that they wouldnt usually buy, the spokesperson says.

By Elizabeth Green

To contact our editorial team please email us at editorial@cnsmedia.com

If you found this article valuable, you may wish to receive our newsletters. Subscribe now to receive the latest news directly into your inbox.

See the original post:
One-fifth of UK consumers reduce meat consumption during outbreak, The Vegan Society reveals - FoodIngredientsFirst

Giant Food Announces Free, Weekly Nutrition-Focused Classes in New Virtual Format – PerishableNews

LANDOVER, Md. Giant Food, the leading greaterWashington D.C.regional grocery chain, today announced that it will be offering free, weekly online nutrition and healthy living classes aimed at supporting the greater community, as well as individuals with chronic illnesses such as diabetes and heart disease. At a time when theCDCrecommends individuals postpone regular, non-urgent healthcare visits and instead use telemedicine when available, these free online classes serve as an extra preventative measure to ensure healthy living habits between doctor visits.

Research shows that even limited short term access to regular health care during a crisis can have long lasting effects on lifestyle conditions like diabetes and heart disease, saidLisa Coleman, MS, RD, and Director of Healthy Living at Giant Food. Our customers are cooking more, often on a limited budget, and are feeling uncertain about how to best adapt their routines. Our goal is to provide easily accessible support during this stressful time which can often exacerbate issues like obesity, heart disease, diabetes and more.

Led by Giants in-house team of 11 licensed nutrition professionals, which has traditionally shared essential nutrition resources to the community via in-person classes, consultations and store tours, these free online classes are an important pivot to continue to offer advice for participants to effectively manage their health through simple diet and lifestyle actions.

People can choose from the following online classes based on their current health needs:

Giant is also offering free personalized online consultations with their team of registered and licensed dietitians for customers who have further questions about their health and wellness. Consultations are by appointment only.

To schedule a consultation, sign up for a class or participate in the weekday Nutrition at Noon series, go togiantfood.com/nutritionor emailnutrition@giantfood.com.

About Giant FoodGiant Food is headquartered inLandover, Md.and operates 163 supermarkets inVirginia,Maryland,Delaware, and theDistrict of Columbiawith approximately 20,000 associates. Included within the 163 stores are 154 full-service pharmacies, 81 full-service PNC Banks and 23 Starbucks locations. With flexible options and convenient solutions, Giant fits all the ways todays busy consumers want to shop whether in store, via Giant Pickup or home delivery from Giant Delivers which combined serves 157 store locations. For more information on Giant, visitwww.giantfood.com.

Originally posted here:
Giant Food Announces Free, Weekly Nutrition-Focused Classes in New Virtual Format - PerishableNews

Private-equity firm raises millions to invest in health and wellness – Yahoo Money

Investors are putting millions of dollars into opportunities focused around healthy foods and a transparent supply chain as consumers demand more plant-based and organic foods.

Gabrielle Ellie Rubenstein, CEO and co-founder of Manna Tree Partners, tells Yahoo Finance her healthy-living investment firm has raised $141.5 million for its fund focused on investments she said are in support of the health of the supply chain.

We have to be able to verify the entire supply chain from farm to fork before we would invest in a company. So the transparent supply chain of the food you are eating is what we invest in, Rubenstein said.

The private-equity firm currently invests in four companies, ranging from those that create ingredients for plant-based foods to those that produce organic beef.

Trends are equally rising, both an increase in plant-based and an increase in natural or organic food,such as pasture-raised eggs or pasture-raised beef, said Rubenstein.

The funds portfolio includes Vital Foods, the largest national brand of pasture-raised eggs that supports small farmers, and Verde Farms, a producer of grass-fed, organic beef.

Rubenstein noted sales for eggs and meat are up during the COVID-19 pandemic as shelter-in-place measures keep families at home.

Our beef company has played a vital role in whether its steak nights or family dinners that might have usually been outside of the home on weekends. It is healthier for you, Rubenstein said.

Manna Trees portfolio also includes investments in MycoTechnology, a manufacturer of mushroom protein, and Nutriati, the largest domestic processor of chick peas, an ingredient often used for plant-based meats and other foods.

The ingredient space is a very active one in plant-based, said Rubenstein.

The stock performance of companies like Beyond Meat (^BYND) and recent partnerships between plant- based foods and major fast-food restaurants has put a spotlight on consumer demand for healthier foods.

The reason we like the ingredients is it allows us to partner with big food companies, said Rubenstein. The ingredients allow you to make food healthier for the average person that might not be able to pay a little bit more for it at a grocery store, she added.

The coronavirus pandemic has created opportunities for some plant-based companies and has also put a greater focus on food supply chains around the world as consumers have been stocking up on food.

Rubenstein says the companies she works with have not been as impacted by COVID-19 because they are smaller and more nimble, relying on co-packers, so workspaces are not as crowded. She stressed that her fund is not focused on companies pivoting It only considers those with manufacturing in place that are cash-flow positive.

Rubenstein said Manna Tree is proud not only of the companies its fund invests in, but also the 131 investors it has tapped across 18 countries, noting that 30% of its investor base is women.

I'm not sure of another fund of our size that would have 30% of their investors be women. It's usually 3%, if you're lucky, said Rubenstein.

Women are great communicators of saying why this is needed, she said. What was unique is in the institutional investors, all institutions or banks we worked with were led by women bankers. So I do see that women supporting women is very alive and well.

Ines covers the U.S. stock market from the floor of the New York Exchange. Follow her on Twitter at@inesreports.

Read more:

It would be unprecedented for a bear market to be this short: Wells Fargo Strategist

Recent rally could be a bear market trap: Miller Tabak Strategist

A view from the trading floor: Algorithms having outsized impact amid coronavirus impact

See original here:
Private-equity firm raises millions to invest in health and wellness - Yahoo Money

Timucuan Parks Foundation and AARP host Virtual Healthy Living Series – iwantabuzz.com

The event will be held on April 29 from a virtual Kingsley Plantation

Jacksonville, Fla., April 27, 2020 Timucuan Parks Foundation and AARP are partnering for a virtual event as a continuation of their Spring 2020 Healthy Living: Fresh Air, Fitness, Friendship and Fun series. The COVID-19 pandemic has kept people out of local parks and preserves so TPF and AARP are turning to Zoom to connect people with nature and local history. Participants are invited to join on Wednesday, April 29 for a virtual Hike into History from 9:30 a.m. to 11 a.m.

As in previous walks, participants will start with some light stretching followed by a virtual tour of Kingsley Plantation led by National Park Service Ranger Emily Palmer. This year marks the 400th anniversary of the first enslaved Africans brought to the United States. The virtual event will remember those enslaved at Kingsley Plantation, honor their stories and celebrate their contributions with a tour of the slave quarters, the Planters House, and the gardens and grounds of Kingsley.

The event is free and open to everyone, but registration is required and can be done at timucuanparks.org/healthy-living. A how-to Zoom guide and event link will be emailed to registrants on Tuesday. For more information, contact Felicia Boyd, program and outreach director with Timucuan Parks Foundation, at [emailprotected] or 904-463-1799.

About Timucuan Parks FoundationThe Timucuan Parks Foundation is a nonprofit organization that preserves, promotes and enhances Jacksonvilles natural areas through community engagement, education and enjoyment. The foundation originated in 1999 with the Preservation Project Jacksonville, Inc. to identify and assist in acquiring the most vulnerable and environmentally sensitive lands in Duval County. The acquisition of lands created the largest urban park system in the United States. The Timucuan Parks Foundation works with its park partners, including the National Park Service, Florida State Parks and the City of Jacksonville, to promote environmental stewardship, the health benefits of the parks and preserves, and an appreciation for Jacksonvilles special outdoor spaces. For more information, visit timucuanparks.org.

See the article here:
Timucuan Parks Foundation and AARP host Virtual Healthy Living Series - iwantabuzz.com

Eight healthy snack options to take to kids when visiting them – The Standard

A good way to teach kids about healthy living is to feed them healthier foods (Shutterstock)

We all need to learn good dieting habits. One of the key secrets to long life, besides eliminating stress and keeping fit, is eating healthy.

ALSO READ: How to make protein powder for your kids at home

Healthy living should start at a young age. And one way to teach kids about it is to feed them healthier foods. They might fret at first because healthy foods dont always taste the best. In the long run, they will realize the importance of eating right once they reap all the benefits.

When youre visiting them, its definitely not a good idea to take candies or fatty foods all the time. Combine all the calories theyre getting from them and youll realize that its a staggering amount.

You have to get creative and choose healthier snacks and meals without compromising on sweetness. Here are a few examples

i.Dark chocolate treats

Dark chocolate and usual milk chocolate are different in so many ways. Dark chocolate is good for the heart, it has antioxidants and it has more minerals and vitamins.

Sure, it doesnt taste exactly the same as milk chocolates but its a much better option. Just make sure they dont eat the whole box at once.

ALSO READ: Recipes around Africa: Matoke from Uganda

ii.Yoghurt smoothies

Yoghurt is one of the tastiest and healthiest treats I know. It replenishes the healthy bacteria in your body and its actually recommended by doctors.

Make it a bit more interesting by making a rainbow smoothie and add some berries in there.

The multicolored layers are achieved either by using drops of food color with each layer or by blending yoghurt with different fruits like blueberries to give it a pop of color.

iii.Diet cake

Making cake at home gives you control of the ingredients. It also gives you freedom to add your own creative twists to make it healthier than store bought cakes.

Reduce the amount of unhealthy ingredients like sugar or replace it with better alternatives.

ALSO READ: Four reasons why you should not gift kids sweet whenever you visit them

iv.Vegetable pizza

Kids arent usually so thrilled after they realize the pizza that was brought is a veggie pizza. You can change all that by tweaking one or two things.

For More of This Stories Subscribe to the Standard Epaper to get a copy of Eve Woman in the Standard

First, work on the presentation. Vegetable pizza often looks bland so you should use colorful ingredients to make it more eye catching. Then double up on the sauce. The strength of vegetable pizza lies in the sauces. These two adjustments will easily win them over.

v.Chicken salad

This is a good replacement for fast food chicken which barely has any nutritional value. The salad is healthy and chicken will make the meal more filling.

There are many ways you can tweak the salad so itll always be something new each time you visit them. Prepare tasty dressing to complete the meal.

vi.Veggie samosas with dip

Vegetable samosas are relatively easy to make. Pair that with a nice saucy or creamy dip for the perfect snack recipe.

vii.Sweet potato fries

Why not ditch the usual potato fries for a better option like sweet potato fries? Once they taste these, theyll literally wonder why theyve been eating potato fries all their lives.

Theyre a perfect mix of sweet and salty and theyre healthy. It doesnt get better than that.

viii.Tropical ice lollies

Theyll be so excited to taste these. You can make a combination of a creamy lolly with just two or three ingredients. Mix some fruit puree into a cup of yogurt then add a bit of cream.

Get some fresh juice of your choice ideally your own blend because its healthier than the manufactured juices. Get your Popsicle tray and pour in the yoghurt layer first then the juice layer.

Keep in the freezer for a few hours. Put them in a cooler so they dont melt before arriving.

Do not miss out on the latest news. Join the Eve Digital Telegram channel HERE.

The views and opinions expressed here are those of the author and do not necessarily reflect the official policy or position of Evewoman.co.ke

See more here:
Eight healthy snack options to take to kids when visiting them - The Standard

QOC promotes healthy living through activities on social media – The Peninsula Qatar

Doha: The Qatar Olympic Committee (QOC) is providing multiple activities and sports events on its social media platforms to encourage the public and followers to exercise sports activities at home, abiding by quarantine measures, and adopting social distancing guidelines.

Through this initiative, QOC is encouraging the individual sport as the best method to maintain the health of the individuals and society physically and psychologically.

Among QOCs vital events and activities is Team Qatar Virtual Run which takes place every Thursday and Friday for 5km, 10km and 21km, along with 2020 Qatar Olympic Committee E-Tournament (FIFA & Pro Evolution 20), as well as Think with Qatar team program which offers questions to the public on events organized by the QOC on its social media platforms, ultimately the winners in these events shall get valuable prizes.

At local media level, the Al Kass TVs broadcaster Mishaal Shakir delivers show at 11 pm titled Live with Qatar team during the holy month of Ramadan, the show hosts athlete from Qatar team on every Wednesday and Friday to focus light on the careers of Qatar team athletes and their achievements. The show on its first day has hosted the Qatari rally driver and sport shooter, Nasser Saleh Al Attiyah who focused light on his sports career and achievements in both Rally and shooting sports.

In another collective effort, many Team Qatar stars from different sport disciplines are providing online - tips and training sessions to help public people to maintain fitness during the home quarantine.

QOCs social media platforms also provide online short video clips to encourage the public and followers to maintain self-physical fitness.

In another scene, the diet expert, Mohammed Al Ahraq presents a 55-minute show (Stay Health with Team Qatar) via the QOCs social media platforms to highlight topics encouraging the child nutrition system.

See the rest here:
QOC promotes healthy living through activities on social media - The Peninsula Qatar

Gut Health and Weight Loss – Bangor Daily News

Scientists have only been studying the role of the gut microbiome on weight loss for a few years, but so far, the results are pretty amazing:

1)People whose weight falls in the obese category have different microbiome profiles than people whose weight is in the normal category.2)It appears some healthy bacteria (probiotics) might actually cut back on how much fat your body absorbs.3)Also, probiotics can play a role in your hunger hormones, making you feel less hungry.4)Other studies show some bacteria in the Lactobacillus family (especially Lactobacillus gasseri) help with fat loss and maybe even prevent weight gain.

So what does this all mean?

Adopting habits that support a healthy gut also appears to support a healthy weight! This includes getting enough sleep, eating gut-friendly foods, exercising regularly, and cutting back on stress.

Its all about creating balance and living a healthy lifestyle!

We outline all of this AND MORE in our newGut Health Guide. This new guide highlights (among other things) the importance of:

Probiotics the good bacteria in your gut & replenishing them, andPrebiotics foods you can eat to keep those probiotics healthy and in balance.

We also include a bunch of our favorite recipes for gut health.

Click here to download your FREE copy of the guide.

Hope you love it!

Wilcox Wellness & Fitness

REFERENCE:www.healthline.com/nutrition/probiotics-and-weight-loss

WANT MORE OF THIS? Be sure to connect with us on Social Media. We post daily on bothFacebookandInstagramfor motivation, inspiration, and helpful tips, tricks, and strategies for healthy living. You can join ourprivate Facebook groupto go even deeper with us orbook a callto see how you can get started training with us in person. We cant wait to connect with you and support you along your journey with healthy living!

Continued here:
Gut Health and Weight Loss - Bangor Daily News

Even during the coronavirus pandemic, the role of public health workers is unrecognized – The Conversation CA

The recent One World: Together at Home virtual concert brought together musical talent from around the world to thank front-line health workers, and raised about US$128 million to support COVID-19 response efforts globally. Celebrities and politicians thanked those on the front lines of the response, including health-care workers and scientists working on COVID-19, those working in the food supply chain, as well as sanitation, delivery and mail workers.

However, nobody acknowledged all the people in public health agencies who have been working tirelessly during this crisis. This includes public health nurses and physicians, health inspectors and educators, laboratory technicians, epidemiologists and statisticians.

These are the people who work in the background to keep us healthy. They process the tests that identify who has the disease. They produce the statistics and models that track how the disease is progressing through our countries.

Read more: Predicting possible outcomes to coronavirus and other pandemics with models and simulations

The lack of acknowledgement doesnt surprise me. The work of public health is invisible, largely unrecognized by society. Despite increases to general spending on medical services, public health agencies are regularly subjected to budget cuts.

I say this not just as a disgruntled public health specialist, upset to see my colleagues overlooked. There is something much more significant about our societys fixation on front-line health care and medical approaches to disease management.

For the past century we have medicalized disease prevention and management for both infectious and chronic diseases. We focus on early detection and treatment (known as screening) and therapies (chemoprophylaxis) for disease prevention. Such medical models run counter to what is known as population health.

In a population health approach, we consider everyone and examine what keeps people healthy. Social and economic determinants of health are much more strongly related to health outcomes than biologic factors.

A population health approach promotes healthy living, healthy environments and healthy social policies balanced with appropriate medical interventions for those who need them. For example, risk of cardiovascular disease can be reduced through a focus on physical activity, good nutrition and smoking cessation. Population health approaches look at the environment in which people live and ensure they have the means and access to services to lead healthy lives.

In contrast, the medical model might focus on finding the people at highest risk for cardiovascular disease through screening tests and then prescribing them drugs. Research has consistently shown that a population health approach has greater impact on health status and is more equitable across society.

What does this mean for our responses to COVID-19? The narrative to date has been dominated by the medical model testing and the search for treatments, ICU beds and ventilators.

We absolutely do need to focus on these factors to ensure we can treat those who develop severe disease. But this fixation has come at the expense of the population health perspective.

And I mean this literally. Newscasts are dominated by clinicians on the front lines and those with a biomedical perspective. How often have we seen Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases, versus Robert Redfield, the head of the Centers for Disease Control and Prevention? Fauci has done an incredible job, but the perspective of Redfield is also important.

The medical model has focused on the immediate needs. To get us out of this, the medical model points to a vaccine which could take years to roll out as the solution.

A population health perspective to COVID-19 considers the impact on the entire population, not just those with disease. It applies an equity lens to ensure no one gets left behind. A population health perspective will consider whether the consequences of continuing our current restrictive measures will cause more harm than good in the long run.

Socio-economic status is the strongest determinant of health. Long-term economic harm may have greater health consequences than COVID-19. But the deaths from COVID-19 are visible and in the news. The deaths that might result from the economic consequences will only be seen in statistics we wont know who was directly affected. They will be invisible, just like public health.

We need to thank our public health workers. We also need to listen to them.

Original post:
Even during the coronavirus pandemic, the role of public health workers is unrecognized - The Conversation CA

Covid19 Folding@home

Coronavirus What were doing and how you can help

Proteins are molecular machines that perform many functions we associate with life. They sense the environment (e.g. in taste and smell), perform work (e.g. muscle contraction and breaking down food), and play structural roles (e.g. your hair). They are made of a linear chain of chemicals called amino acids that, in many cases, spontaneously fold into compact, functional structures. Much like any other machine, its how a proteins components are arranged and move that determine the proteins function. In this case, the components are atoms.

Viruses also have proteins that they use to suppress our immune systems and reproduce themselves.

To help tackle coronavirus, we want to understand how these viral proteins work and how we can design therapeutics to stop them.

There are many experimental methods for determining protein structures. While extremely powerful, they only reveal a single snapshot of a proteins usual shape. But proteins have lots of moving parts, so we really want to see the protein in action. The structures we cant see experimentally may be the key to discovering a new therapeutic.

Using football as an analogy for the experimental situation, its as if you could only see the players lined up for the snap (the single arrangement the players spend the most time in) and were blind to the rest of the game.

Continue reading here:
Covid19 Folding@home

Where are the robots when you need them! – Robohub

Looking at the Open Source COVID-19 Medical Supplies production tally of handcrafted masks and faceshields, were trying to answer that question in our weekly discussions about COVID-19, robots and us. We talked to Rachel McCrafty Saddhas been building systems and automation for COVID mask making, as the founder of Project Mask Making and #distillmyheart projects in the SF Bay Area, an artist and also as Executive Director of Ace Monster Toys makerspace/studio. Rachel has been organizing volunteers and automating workflows to get 1700 cloth masks hand sewn and distributed to people at risk before the end of April. Wheres my f*king robot! was the theme of her short presentation.

If you think that volunteer efforts arent able to make a dent in the problems, heres the most recent (4/20/20) production tally for the group Open Source COVID-19 Medical Supplies, who speak regularly on this web series. One volunteer group has tallied efforts by volunteers across 45 countries who have so far produced 2,315,559 pieces of PPE. And thats not counting the #distillmyheart masks. Heres Rachels recent interview on KTVU. Those masks arent going to make themselves, people!

We also heard from Robin Murphy, Expert in Rescue Robotics & Raytheon Professor at Texas A&M University, who updated her slides on the way in which robots are being used in COVID-19 response. You can find more information on Robotics for Infectious Diseases, an organization formed in response to the Ebola outbreak and chaired by Dr Murphy. There is also a series of interviews answering any questions a roboticist might have about deploying robots with public health, public safety and emergency managers.

Next we heard from Missy Cummings, Expert in Robotics Safety & Professor at Duke University. Ive been doing robotics, certification testing and certification for almost 10 years now. I started out in drones. And then kind of did a segue over into driverless cars and I also work on medical systems. So I work in this field of safety critical systems, where the operation of the robot in terms of the drone or the car or the medical robot, it can actually do damage to people if not designed correctly. Heres a link to a paper that Ive written for AI Magazine thats really looking at the maturity of driverless cars.

I spent a ridiculous amount of time on Capitol Hill trying to to be a middle ground between, yes, these are good technologies. We want to do research and investment and keep keep building a capacity. But no, were not ready to have widespread deployment yet. And I dont care what Elon Musk says youre not getting full self driving anytime soon.

Any reasoning system has to go through four levels of reasoning, you start at the basics, what we call skill based reasoning, then you go up to rule knowledge and expert based reasoning. And so where do we see that in cars? When you learn to drive you had to learn skill based reasoning, which was learning for example, how to track light lines on the road. Once you did that, maybe 20 minutes to learn that then you never actually have a problem with that again.

So once you have the cognitive capacity that youve learned skills, then you have enough spare mental capacity to think about rule based reasoning. And thats when you start to understand, Okay, I see this octagon in front of me, it is a stop sign its read, I know that what it means theres a set of procedures that go along with stopping and Im going to follow those when I see it. Then once you have the rules of the environment that youve learned, then you have the spare capacity to start thinking about knowledge base reasoning, the big jump between rule and knowledge base reasoning is the ability to judge under uncertainty. So this is where you start to see the uncertainty arrow growing. So when you go up to knowledge base reasoning, you are starting to have to make guesses about the world with imperfect information.

So I like to show this picture of a stop sign partially obscured by vegetation. There are many many, many driverless car system computer vision systems right now that cannot figure this out that if they see some level of partially obscured stop sign, they just cannot see because they dont see the way that we see. They dont see the complete picture. And so they dont judge that theres a stop sign there. And you might have seen the recent case of the Tesla being tricked by a partially modified 35 mile per hour sign with a little bit of tape to make it see 85 miles per hour. Its a really good illustration of just how brittle machine learning deep learning is when it comes to perceptual based reasoning. And then we get to the highest level of reasoning where you really have to make judgments under maximum uncertainty.

I love this illustration of this stop sign with these four different arrows. You cannot do this, you cannot turn left, you cannot go right, you cannot go straight and you cannot go back. So Id be curious, Id like to see what any driverless car would do in this situation. Because what do you do in the situation? You have to break one of these rules, you have to make a judgment, you have to figure out what is the best possible way to get yourself out of the system. And it means that youre going to have to break rules inside the system. So the expert base reasoning knowledge base reasoning there is what we call top down reasoning, its you taking experience judgment in the world that youve had. As youve gotten older in life and had more experiences, you bring that to bear to make better guesses about what you should do in the future.

Bottom up reasoning is, is essentially what is happening in machine learning. Youre taking all the bits and bytes of information from the world, and then processing that to then make some kind of action. So right now Computers are really good at skill based reasoning, some rule based reasoning, humans are really the best at knowledge and expert based reasoning. And this is something we call functional allocation. But the problem is theres a big break between rule and knowledge. Driverless cars cannot do this right now, until we can make that jump into knowledge and expert base reasoning. What are we going to do have to do? [Missy Cummings, Robot Safety Expert]

Michael Sayre, CEO Cognicept said Im working with a company called Cognizant as CEO. Were essentially solving a lot of the problems that Missy highlighted, which is that, you know, when we look at autonomy, and moving robots into the real world, there are a lot of complexities about the real world that cause what we call edge case failure in these systems. And so what weve built is essentially a system that allows a confused robot to dial out for human operator.

Human in the loop is not a new idea. This is something that self driving cars have used. What weve built is essentially a system and a service that allows this confused robot to dialogue for help on real time basis. We essentially listen for intervention requests from robots. So that can be an error code, or, you know, some kind of failure of the system timeouts, whatever it is really, we can listen for that event. And then we cause a ticket to be registered in our system, which our operators will then see, that connects them to the robot, they can kind of get a sense of whats happening in the robots environment, they can get sensor information, populated in a 3d canvas, we can see videos and so forth, that allow the operator to make judgments on the robots behalf.

Self driving vehicles is probably not the best example for us. But maybe you would be able to use our system in something like a last mile delivery vehicle, which will face a lot of the same problems. Maybe the robots uncertain about whether it can cross the road. We can have a look at the video feed from that robot, understand what the traffic signals are saying, or what the environment looks like. And then give the robotic command to essentially help it with getting past the scenario that caused that Case failure. So we see this as sort of a way to help get robots into more useful service.

You know, right now, even at 1% failure rate for a lot of these applications can be a deal breaker. You know, we, especially for self driving cars, as everybody mentioned, you know, the cost of failure is really high. But even in other sort of less critical cases, like in building delivery, you see, you know, if something is spinning around in a circle or not performing its job, it causes people to lose confidence in the system stopped using it. And its also you know, during the time that its confused, not performing its function. So we essentially built this system as a way to bring robots into a broader range of applications and improve the sort of uptime of the system so that it doesnt get into these positions where its stuck during its operation.

Similarly, we have robots that get lost in spaces that are widely variable. So you know, a warehouse that has boxes or pallets that move in and out of the space very frequently. Thats going to confuse the robot because its internal map is static in most cases. And when you have a very large change, the robots going to be confused about its location, and then not be able to proceed with its its normal operation. Thats something that we can help with we essentially will be able to look at the robots environment and understand where it is in its space and then update its location. Again, you know, we look at different types of obstacles. You know, a plastic bag is not really an obstacle, we can, you can run through that. But on a LIDAR, it shows up the same way as a pile of bricks.

So by having a human in the loop element, we are able to sort of handle these edge case failures and get robots to perform functions that they wouldnt otherwise be able to perform and be useful in applications that were maybe too challenging for full autonomy. I think a lot of it has to do with sort of how dangerous is the robot in question. So, you know, for a self driving vehicle, very dangerous, right, weve got a half ton of steel, you know, moving at, you know, relatively rapid speeds. This is a dangerous system.

On the other hand, in building delivery robots, were doing some work in quarantine zones, making deliveries in buildings that allow social distancing to be maintained. We can put needed supplies inside of this delivery robot and send it in a building to the delivery room. So worst case scenario, we might bump into somebody. Its just inconvenient and might sort of ruin the either the economics of the usefulness of the robot. That would be a good case for these less critical systems. So things like in-building delivery, material handling and logistics spaces. Maybe like a picking arm like a robot arm pulling things out of a box and putting it into a shipping container, or into another robot for in-building delivery.

While we try to get as fast as we can, youre still talking about 30 seconds, maybe before you can really respond to the problem in a meaningful way. So, you know, 30 seconds is an eternity for a self driving vehicle, whereas for an in-building delivery robot, its not a big deal. So I think you know, the answer to that its pretty application dependent and also system dependent, you know, how dangerous is the system inherently? [Michael Sayre, CEO of Cognicept]

Rex St John, ARM IOT Ecosystem Evangelist presented an unusual COVID-19 response topic. This isnt quite a robotics topic. But a few weeks ago, I began working on a project called Rosetta@home. So if youre not familiar, theres a lot of researchers that are studying protein folding, and other aspects of biological research. And they dont have the funding to pay for supercomputer time. So what they do is they they distribute the research workloads to volunteer networks all around the world through this program called boink. So theres a lot of these programs, theres SETI@home, and Rosetta@home and Fold@home. And theres all these people that volunteer their extra compute cycles by downloading this client. And then researchers upload work, jobs to the cloud, and then those jobs are distributed to these home computers.

So because I work at arm, we realize that Fold@home and Rosetta@home. are two projects which are used specifically to study protein folding. They did not have arm 64 bit clients available, which means you cant run them on a Raspberry Pi four, you cant run them on some of the newer arm hardware. So there are a lot of people in the community that were wanting to help out with Fold@home and Rosetta@home, which are now being used extensively by researchers specifically to study COVID-19. So we put together this community project. And it came together very, very quickly. Because once everybody learned about this opportunity, they jumped on board very quickly. So what happened was these guys from Neocortex, its a startup out of San Jose. They jumped on this and their CTO ported all the key libraries from Rosetta@home to arm 64 and then within a couple weeks a week or two actually, were now up to 793 arm 64 bit devices that are supporting researchers studying COVID-19 so anybody that wants to help out if youve got a Raspberry Pi four or an arm 64 bit device you can install Rosetta@home on your Raspberry Pi four and begin crunching on proteins to help researchers fight back COVID-19. https://www.neocortix.com/coronavirus

You can see this is the spike protein right there of COVID-19. COVID-19 uses the spike protein to sort of latch on to the the receptors of human cells and thats how it kind of invades your body. So theyre doing a lot of work to understand the structure and behavior that spike protein on Rosetta and Fold@home. [Rex St John ARM IoT Evangelist]

Ken Goldberg, Director of CITRIS People and Robots Initiative said I do have one thought that Id like to share that occurred to me this week, which is that I wonder if were shifting from what used to be called the High Tech High Touch concept from John Naisbitt. He wrote Mega Trends about how we were moving as we got toward more high tech, wed also just as much crave that touch. And I wonder if were moving toward a low touch future where we actually will see new value in things that are dont involve touch. Its been so interesting for me to be you know, to be in the house. Ive gotten a whole new appreciation for things like washing machines and even vacuum cleaners. Theyre incredible these mechanisms that help us do things, that rather than us reaching down and touching everything they basically do it for us.

Ive been thinking about you before this pandemic. There are a lot of things out there like robot vending machines that I was a little skeptical about. And I thought, well, I dont really see whats the big advantage, given a choice Id rather have a human making a hamburger or coffee. But now Im starting to really think that equation has changed. And I wonder if thats going to change permanently. In other words, are we actually going to see this a real trend toward things like these robot coffee making baristas and robot burgers like Creator, the company in San Francisco. or Miso robotics is developing fast food making robots. I think its time to really reevaluate those trends because I think there is going to be an actual visceral appeal for this kind of low touch future. [Ken Goldberg CITRIS People and Robots]

Therell be more next week on Tuesday April 28 so sign up for COVID-19, robots and us with guest speakers focusing on regulations, risks and opportunities:

guest author

Visit link:
Where are the robots when you need them! - Robohub

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Prot – PharmiWeb.com

MagForce AG / Key word(s): StudyMagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

27-Apr-2020 / 23:51 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.

MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Protocol for the next Stage of Pivotal U.S. Single-Arm Study for the Focal Ablation of Intermediate Risk Prostate Cancer with the NanoTherm Therapy System

Berlin, Germany, and Nevada, USA, April 27, 2020 - MagForce AG (Frankfurt, Scale, Xetra: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, together with its subsidiary MagForce USA, Inc., today announced that FDA approval for a streamlined trial protocol, for the next stage of the Company's pivotal U.S. study with the NanoTherm therapy system for the focal ablation of intermediate risk prostate cancer was received. The next stage of the clinical trial is being initiated with three well-respected urological centers in Texas, Washington and Florida who actively enrolled patients in Stage 1.

The streamlined procedure will allow the patient treatment to be completed within one day at one of MagForce's three out-patient treatment facilities and is possible because of limited side effects that were observed at each step of the procedure in Stage 1.

The next stage of the study will be conducted in phases to ensure early on that the minimal side effects observed in Stage 1, with a drawn out procedure, are maintained in the streamlined one day procedure. Treatment of the first 5 to10 subjects should be sufficient to affirm the minimal side effects as expected.

COVID-19 impact: While there are many restrictions that have been applied such as "Shelter at Home" and eliminating state to state travel via car or via plane; however, MagForce is still working diligently with its physician investigators. Exemptions exist for healthcare workers, such as MagForce's USA staff at MagForce USA clinical facilities. Clearly MagForce USA can conduct the trial in its out-patient facilities and has developed COVID-19 infection control procedures for staff and study subjects. All this effort has caused a certain delay but MagForce is confident the next stage of the clinical trial will not be unduly delayed since MagForce USA will conduct the trial from its facilities.

MagForce is still hopeful that the COVID-19 pandemic will not cause significant delay beyond 2020 to complete this single-arm clinical trial.

- End of Insider Information -

Contact:MagForce AG, Max-Planck-Strae 3, 12489 BerlinBarbara von FrankenbergVice President Communications & Investor RelationsT +49-30-308380-77E-Mail: bfrankenberg@magforce.com

Disclaimer

This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated.

27-Apr-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at http://www.dgap.de

Read the original:
MagForce AG: MagForce USA, Inc. has received FDA Approval to proceed with its Streamlined Trial Prot - PharmiWeb.com

Antiaging Products and Services Market Size, Revenue, Share, Latest trends, Application, Growth in 2020. Top Companies are Elizabeth Arden Inc,…

This Antiaging Products and Services market analysis report forecasts the future trends and highlights the specific areas wherein the impact is expected to be huge. The document gathers the market data culled from market research efforts, compiles survey results, reviews data pulled from available sources for demographics and examines the statistics that tells the size of the target market. Then the information is analyzed to determine the profile of target market. Consequently, the global Antiaging Products and Services market report gains adequate attention from the audience and gets well received. This is the robust and extremely informative market research report to opt.

Request for Sample Copy or PDF Herehttps://www.databridgemarketresearch.com/request-a-sample?dbmr=global-antiaging-products-and-services-market

Theglobal antiaging products and services marketis expected to reach USD 859.11 billion by 2025, from USD 347.58 billion in 2017 growing at a CAGR of 11.8% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Some of the major players operating in the globalantiaging products and services marketareChanel SA, GlaxoSmithKline Plc, Allergan Inc, Neutrogena Corporation, Procter & Gamble, Elizabeth Arden Inc, Johnson & Johnson, Orlane SA, Revlon Inc, Novartis International AG, Unilever PLC, Avon Products Inc, Woodridge Labs Inc, Beiersdorf, LOral SA, Merck & Company Inc, Christian Dior, Valeant Pharmaceuticals International, NeoStrata Company Inc, Bayer Schering Pharma AG, F. Hoffmann-La Roche Ltd among others.

Market Definition:Global Antiaging Products and Services Market

As the skin ages, it loses its natural elasticity and becomes thinner, more fragile and laxer, taking on a wrinkled appearance. In modern society, there is a great increase in the search for eternal youth and an insatiable appetite for methods which could turn back the clock. This has triggered an explosion in the antiaging industry. In addition, technological advances in medicine for the prevention and treatment of deadly diseases help to increase life expectancy.

The aging process of the skin generally has two kinds of forms: natural aging and light aging. There are various factors which directly affect intrinsic aging such as ethnicity, anatomic variations, hormonal changes, extrinsic aging, drugs, smoking and sunlight exposure. These aging conditions can be treated by the antiaging products such as UV absorbers, anti-wrinkle products, anti-stretch products, others and services and therapies. For anti-aging, the cosmetics are commercially available products that can be used to improve the appearance of the skin. People are constantly demanding for more effective products that can essentially beautify the appearance and has resulted in augmented basic science research and product development in the cosmetics industry.

According to news provided by Stempeutics Research Pvt. Ltd., in July 2015, Cipla (India) launched a new anti-aging product which uses human bio-active factors. The product was launched with a brand name Cutisera, developed by Stempeutics. This product will be used for reducing fine lines and wrinkles, lightening dark spots, evening skin tone, improving skin firmness and improving skin hydration.

Browse Detailed TOC Herehttps://www.databridgemarketresearch.com/toc?dbmr=global-antiaging-products-and-services-market&raksh

Market Segmentation:Global Antiaging Products and Services Market

The global antiaging products and services market is segmented based on product, therapies and services and geographical segments.

Based on product, the market is segmented into UV absorbers, anti-wrinkle products, anti-stretch products and others.

Based on therapies and services, the market is segmented into eye-lid surgery, abdominoplasty, hormone replacement therapy, breast augmentation, liposuction, gene therapy, injectable skin, botox, telomere based therapy, rejuvenation and dermal fillers, sclerotherapy, anti-pigmentation therapy, hair restoration services and chemical peels.

Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.

Major Market Drivers and Restraints:

Key Developments in the Market:

Competitive Analysis:Global Antiaging Products and Services Market

The global antiaging products and services market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of antiaging products and services market for global, Europe, North America, Asia Pacific and South America.

Reasons to Purchase this Report

Customization of the Report

Want Full Report? Enquire Herehttps://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-antiaging-products-and-services-market&raksh

About Data Bridge Market Research:

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475 Mail:[emailprotected]

Read the original:
Antiaging Products and Services Market Size, Revenue, Share, Latest trends, Application, Growth in 2020. Top Companies are Elizabeth Arden Inc,...

Aytu BioScience Signs Development Agreement with Sterling Medical Devices to Advance the Development of Healight as a Potential Coronavirus Treatment…

Company has Partnered with Sterling Medical to Finalize the Development of Cedars-Sinai-Developed 'Healight' Medical Device for Use in Patients with Coronavirus

ENGLEWOOD, CO / ACCESSWIRE / April 27, 2020 / Aytu BioScience, Inc. (AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs announced today that it has signed an agreement with Sterling Medical Devices ("Sterling") to finalize the development of Healight, a novel endotracheal catheter, as a potential treatment for coronavirus.

The company announced last week that it licensed exclusive worldwide rights to the Healight technology from Cedars-Sinai for all endotracheal and nasopharyngeal indications. The patent-pending Healight Platform has been in development since 2016 by the Medically Associated Science and Technology (MAST) team at Cedars-Sinai. Following their pre-clinical findings that Healight may be a safe and effective antiviral and antibacterial treatment, the team engaged Sterling to rapidly develop a novel endotracheal device to help combat coronavirus.

"Sterling has been working with the Cedars-Sinai team for the past several weeks on a very accelerated schedule to develop this much needed device," said Dan Sterling, President of Sterling Medical Devices. "We are happy to now be partnering with Aytu to further advance this critical project as fast as we possibly can for the many patients in need."

"The Aytu team is very pleased to be working with Sterling Medical on this important development program and in the fight against coronavirus," stated Josh Disbrow, Chairman and CEO of Aytu BioScience. Disbrow further commented, "Sterling has a stellar reputation as a best-in-class medical device product firm with more than 21 years of experience, over 1,100 projects engineered, with none failing to receive FDA regulatory approval upon submission. Our team is actively engaged with our colleagues at Sterling in an effort to finalize the device development, with hope of enabling human use in the very near future."

The company believes the Healight platform technology has the potential to positively impact outcomes for critically ill patients infected with coronavirus and other infections. Aytu, with support of the team at Cedars-Sinai, is working with the FDA to determine an expedited regulatory process to potentially enable near-term use of the technology initially as a coronavirus intervention for critically ill intubated patients.

About Aytu BioScience, Inc.

Aytu BioScience, Inc. is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The Company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The primary care portfolio includes (i) Natesto, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T"), (ii) ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and (iii) Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes (i) AcipHex Sprinkle, a granule formulation of rabeprazole sodium, a commonly prescribed proton pump inhibitor; (ii) Cefaclor, a second-generation cephalosporin antibiotic suspension; (iii) Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions; and (iv) Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency. Aytu recently acquired exclusive U.S. distribution rights to the COVID-19 IgG/IgM Rapid Test. This coronavirus test is a solid phase immunochromatographic assay used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus in human whole blood, serum or plasma. This point-of-care test has been validated in a 126 patient clinical trial in China and has received CE marking.

Aytu recently acquired Innovus Pharmaceuticals, a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer healthcare products designed to improve men's and women's health and vitality. Innovus commercializes over thirty-five consumer health products competing in large healthcare categories including diabetes, men's health, sexual wellness and respiratory health. The Innovus product portfolio is commercialized through direct-to-consumer marketing channels utilizing the Company's proprietary Beyond Human marketing and sales platform.

Story continues

Aytu's strategy is to continue building its portfolio of revenue-generating products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets. For more information visit aytubio.com and visit innovuspharma.com to learn about the Company's consumer healthcare products.

About Sterling Medical Devices

Founded in 1998, Sterling Medical Devices (SMD), specializes in the product design and engineering of medical devices for the healthcare industry. Dedicated to resolving their clients' medical device design and engineering challenges, SMD addresses the whole development process, including, product design and human factors, systems, software, electronics, mechanical, quality, and compliance. The company utilizes the latest tools and technology to streamline the engineering process to speed regulatory approval of Class I, II and III devices. To date, the company has spearheaded the production of over 1,100 projects for more than 300 clients. SMD is internationally recognized and is FDA QSR 21, CFR 820, and 21 CFR Part 11 compliant, ISO 13485 registered, and IEC 62304, ISO 14971, IEC 60601, and IEC 62366 compliant. For more information, please visit http://www.sterlingmedicaldevices.com or call 201.227.7569 x2.

Forward-Looking Statement

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as ''may,'' ''will,'' ''should,'' ''forecast,'' ''could,'' ''expect,'' ''suggest,'' ''believe,'' ''estimate,'' ''continue,'' ''anticipate,'' ''intend,'' ''plan,'' or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: market and other conditions, the regulatory and commercial risks associated with introducing the COVID-19 Rapid Test, our ability to enforce the exclusivity provisions of the distribution agreement, the reliability of serological testing in detecting COVID-19, shipping delays and their impact on our ability to introduce the COVID-19 Rapid Test, the ability of the COVID-19 Rapid Test to accurately and reliably test for COVID-19, the manufacturer of the COVID-19 Rapid Test's ability to manufacture such testing kits on a high volume scale, manufacturing problems or delays related to the COVID-19 Rapid Test, our ability to satisfy any labelling conditions or other FDA or other regulatory conditions to sell the COVID-19 Rapid Test Kit, the demand or lack thereof for the COVID-19 Rapid Test Kit, our ability to obtain additional COVID-19 Rapid Tests to meet demand, our ability to secure additional tests if the manufacture of the COVID-19 Rapid Tests is unable to meet demand, the effects of the business combination of Aytu and the Commercial Portfolio and the recently completed merger ("Merger") with Innovus Pharmaceuticals, including the combined company's future financial condition, results of operations, strategy and plans, the ability of the combined company to realize anticipated synergies in the timeframe expected or at all, changes in capital markets and the ability of the combined company to finance operations in the manner expected, the diversion of management time on Merger-related issues and integration of the Commercial Portfolio, the ultimate timing, outcome and results of integrating the operations the Commercial Portfolio and Innovus with Aytu's existing operations, risks relating to gaining market acceptance of our products, obtaining or maintaining reimbursement by third-party payors for our prescription products, the potential future commercialization.

SOURCE: Aytu BioScience, Inc.

View source version on accesswire.com: https://www.accesswire.com/587152/Aytu-BioScience-Signs-Development-Agreement-with-Sterling-Medical-Devices-to-Advance-the-Development-of-Healight-as-a-Potential-Coronavirus-Treatment

See the article here:
Aytu BioScience Signs Development Agreement with Sterling Medical Devices to Advance the Development of Healight as a Potential Coronavirus Treatment...

Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited – Yahoo Finance

ENGLEWOOD, CO / ACCESSWIRE / April 23, 2020 / Aytu BioScience, Inc. (AYTU) (the "Company"), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, announced the signing of a definitive agreement (the "Agreement") with Singapore-based Biolidics, Limited (SGX: 8YY; "Biolidics") to exclusively distribute Biolidics' COVID-19 IgG/IgM Rapid Test in the United States.

Under the terms of the Agreement, Aytu will exclusively distribute Biolidics' COVID-19 IgG/IgM rapid antibody test in the United States. Aytu has committed to purchase 500,000 tests within one business day from the date of signing of the Agreement. As an additional component of Aytu's exclusivity, the Company has committed to purchase a minimum of 1,250,000 tests within the first three months of the Agreement.

Biolidics' COVID-19 IgG/IgM Rapid Test has been issued Provisional Authorization for distribution by Singapore's Health Science's Authority (HSA), and the product has been authorized for export from Singapore. Biolidics' COVID-19 IgG/IgM Rapid Test will be supplied from Biolidics' facility in Singapore.

Aytu will collaborate with Biolidics and lead the U.S. clinical trials processes and plans to complete and obtain U.S. Food and Drug Administration ("FDA") 510k regulatory filing clearance of the COVID-19 IgG/IgM rapid test kits.

Josh Disbrow, Chief Executive Officer of Aytu BioScience, commented, "We are pleased to be partnering with Biolidics in distributing this COVID-19 rapid test in the U.S. With the continued call in the United States for increased COVID-19 testing, we are entering this distribution Agreement at an excellent time. We have experienced significant demand for our current COVID-19 rapid test, so adding this test to our product offering will enable us to better meet the high demand in the U.S. We look forward to a productive working relationship with Biolidics and thank them for their confidence in allowing Aytu to take this product to market in the United States."

Incorporated in 2009 and listed on the Singapore Stock Exchange, Biolidics Limited is a Singapore-based precision medicine medical technology company with a focus in developing a portfolio of innovative diagnostic solutions to lower healthcare costs and improve clinical outcomes.

About Aytu BioScience, Inc.

Aytu BioScience, Inc. is a commercial-stage specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. The Company currently markets a portfolio of prescription products addressing large primary care and pediatric markets. The primary care portfolio includes (i) Natesto, the only FDA-approved nasal formulation of testosterone for men with hypogonadism (low testosterone, or "Low T"), (ii) ZolpiMist, the only FDA-approved oral spray prescription sleep aid, and (iii) Tuzistra XR, the only FDA-approved 12-hour codeine-based antitussive syrup. The pediatric portfolio includes (i) AcipHex Sprinkle, a granule formulation of rabeprazole sodium, a commonly prescribed proton pump inhibitor; (ii) Cefaclor, a second-generation cephalosporin antibiotic suspension; (iii) Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions; and (iv) Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various for infants and children with fluoride deficiency. Aytu recently acquired U.S. distribution rights to two COVID-19 IgG/IgM rapid tests. These coronavirus tests are solid phase immunochromatographic assays used in the rapid, qualitative and differential detection of IgG and IgM antibodies to the 2019 Novel Coronavirus in human whole blood, serum or plasma.

Aytu recently acquired Innovus Pharmaceuticals, a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer healthcare products designed to improve men's and women's health and vitality. Innovus commercializes over thirty-five consumer health products competing in large healthcare categories including diabetes, men's health, sexual wellness and respiratory health. The Innovus product portfolio is commercialized through direct-to-consumer marketing channels utilizing the Company's proprietary Beyond Human marketing and sales platform.

Story continues

Aytu's strategy is to continue building its portfolio of revenue-generating products, leveraging its focused commercial team and expertise to build leading brands within large therapeutic markets. For more information visit aytubio.com and visit innovuspharma.com to learn about the Company's consumer healthcare products.

Forward-Looking Statement

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as ''may,'' ''will,'' ''should,'' ''forecast,'' ''could,'' ''expect,'' ''suggest,'' ''believe,'' ''estimate,'' ''continue,'' ''anticipate,'' ''intend,'' ''plan,'' or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: our ability to successfully commercialize Healight Platform Technology, our ability to obtain FDA approval for the Healight Platform Technology, the effectiveness of the Healight Platform Technology in treating patients with COVID-19 or other illnesses, our ability to adequately protect the intellectual property associated with the Healight Platform Technology, regulatory delays, the reliability of the Healight Platform Technology in killing viruses and bacteria, market acceptance of UV based medical devices, risks associated with the our COVID-19 rapid tests including our ability to enforce the exclusivity provisions of the distribution agreements, the reliability of serological testing in detecting COVID-19, shipping delays and their impact on our ability to introduce the COVID-19 rapid tests, the ability of the COVID-19 rapid tests to accurately and reliably test for COVID-19, the manufacturers of the COVID-19 rapid tests' ability to manufacture such testing kits on a high volume scale, manufacturing problems or delays related to the COVID-19 Rapid Test, our ability to satisfy any labelling conditions or other FDA or other regulatory conditions to sell the COVID-19 rapid test kits, the demand or lack thereof for the COVID-19 rapid test kits, our ability to obtain additional COVID-19 rapid tests to meet demand, our ability to secure additional tests if the manufactures of the COVID-19 rapid tests are unable to meet demand, the effects of the business combination of Aytu and the Commercial Portfolio and the recently completed merger ("Merger") with Innovus Pharmaceuticals, including the combined company's future financial condition, results of operations, strategy and plans, the ability of the combined company to realize anticipated synergies in the timeframe expected or at all, changes in capital markets and the ability of the combined company to finance operations in the manner expected, the diversion of management time on Merger-related issues and integration of the Commercial Portfolio, the ultimate timing, outcome and results of integrating the operations the Commercial Portfolio and Innovus with Aytu's existing operations, risks relating to gaining market acceptance of our products, obtaining or maintaining reimbursement by third-party payors for our prescription products, the potential future commercialization of our product candidates, the anticipated start dates, durations and completion dates, as well as the potential future results, of our ongoing and future clinical trials, the anticipated designs of our future clinical trials, anticipated future regulatory submissions and events, our anticipated future cash position and future events under our current and potential future collaboration. We also refer you to the risks described in ''Risk Factors'' in Part I, Item 1A of the Company's Annual Report on Form 10-K and in the other reports and documents we file with the Securities and Exchange Commission from time to time.

Contact for Media and Investors:

James CarbonaraHayden IR(646) 755-7412james@haydenir.com

Contact for COVID-19 IgG/IgM Rapid Test and Healight-Related Inquiries:

COVID-19@aytubio.com

SOURCE: Aytu BioScience, Inc.

View source version on accesswire.com: https://www.accesswire.com/586556/Aytu-BioScience-Announces-Exclusive-Distribution-Agreement-for-COVID-19-IgGIgM-Rapid-Test-with-Singapore-Based-Biolidics-Limited

Read more from the original source:
Aytu BioScience Announces Exclusive Distribution Agreement for COVID-19 IgG/IgM Rapid Test with Singapore-Based Biolidics Limited - Yahoo Finance

Nanomedicine Market Overview, Top Companies, Region, Application and Global Forecast by 2026 – Latest Herald

The world is not only fighting a health pandemic but also an economic one, as the Novel Coronavirus (COVID 19) casts its long shadow over economies around the globe. The complete lockdown situation in several countries, has directly or indirectly impacted many industries causing a shift in activities like supply chain operations, vendor operations, product commercialization, etc. In the latest report on Nanomedicine Market, published by Market Research Intellect, numerous aspects of the current market scenario have been taken into consideration and a concise analysis has been put together to bring you with a study that has Pre- and Post-COVID market analysis. Our analysts are watching closely, the growth and decline in each sector due to COVID 19, to offer you with quality services that you need for your businesses. The report encompasses comprehensive information pertaining to the driving factors, detailed competitive analysis about the key market entities and relevant insights regarding the lucrative opportunities that lie in front of the industry players to mitigate risks in such circumstances.

It offers detailed research and analysis of key aspects of the global Nanomedicine market. The market analysts authoring this report has provided detailed information on growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Nanomedicine market. Market participants can use the market analysis to plan effective growth strategies and prepare for future challenges in advance. Each trend in the global Nanomedicine market is carefully analyzed and investigated by market analysts.

For Better Understanding, Download Sample PDF Copy of Nanomedicine Market Research Report @ https://www.marketresearchintellect.com/download-sample/?rid=201321&utm_source=LHN&utm_medium=888

**Our SAMPLE COPY of the report gives a brief introduction of the Nanomedicine market, Detailed TOC, key players of the market, list of tables and figures and comprising key countries regions.**

The Major Players in Global Nanomedicine Market:

Global Nanomedicine Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=201321&utm_source=LHN&utm_medium=888

Nanomedicine Market Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Some Notable Report Offerings:

-> We will give you an assessment of the extent to which the market acquire commercial characteristics along with examples or instances of information that helps your assessment.

-> We will also support to identify standard/customary terms and conditions such as discounts, warranties, inspection, buyer financing, and acceptance for the Nanomedicine industry.

-> We will further help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in Nanomedicine industry.

-> Furthermore, we will help you to identify any crucial trends to predict Nanomedicine market growth rate up to 2026.

-> Lastly, the analyzed report will predict the general tendency for supply and demand in the Nanomedicine market.

Have Any Query? Ask Our Expert@ https://www.marketresearchintellect.com/need-customization/?rid=201321&utm_source=LHN&utm_medium=888

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Nanomedicine market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Nanomedicine market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Nanomedicine Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Nanomedicine Market Size, Nanomedicine Market Growth, Nanomedicine Market Forecast, Nanomedicine Market Analysis

Our Trending Reports

Commercial Greenhouse Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Deep Learning Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Digital Out Of Home Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See original here:
Nanomedicine Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald